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Abstract
Background: Silicosis is a complex lung disease for which no successful treatment is available and therefore lung
transplantation is a potential alternative. Tumor necrosis factor alpha (TNFa) plays a central role in the pathogenesis of
silicosis. TNFa signaling is mediated by the transcription factor, Nuclear Factor (NF)-kB, which regulates genes controlling
several physiological processes including the innate immune responses, cell death, and inflammation. Therefore, inhibition
of NF-kB activation represents a potential therapeutic strategy for silicosis.
Methods/Findings: In the present work we evaluated the lung transplant database (May 1986–July 2007) at the University
of Pittsburgh to study the efficacy of lung transplantation in patients with silicosis (n=11). We contrasted the overall
survival and rate of graft rejection in these patients to that of patients with idiopathic pulmonary fibrosis (IPF, n=79) that
was selected as a control group because survival benefit of lung transplantation has been identified for these patients. At
the time of lung transplantation, we found the lungs of silica-exposed subjects to contain multiple foci of inflammatory cells
and silicotic nodules with proximal TNFa expressing macrophage and NF-kB activation in epithelial cells. Patients with
silicosis had poor survival (median survival 2.4 yr; confidence interval (CI): 0.16–7.88 yr) compared to IPF patients (5.3 yr; CI:
2.8–15 yr; p=0.07), and experienced early rejection of their lung grafts (0.9 yr; CI: 0.22–0.9 yr) following lung transplantation
(2.4 yr; CI:1.5–3.6 yr; p,0.05). Using a mouse experimental model in which the endotracheal instillation of silica reproduces
the silica-induced lung injury observed in humans we found that systemic inhibition of NF-kB activation with a
pharmacologic inhibitor (BAY 11-7085) of IkBa phosphorylation decreased silica-induced inflammation and collagen
deposition. In contrast, transgenic mice expressing a dominant negative IkBa mutant protein under the control of epithelial
cell specific promoters demonstrate enhanced apoptosis and collagen deposition in their lungs in response to silica.
Conclusions: Although limited by its size, our data support that patients with silicosis appear to have poor outcome
following lung transplantation. Experimental data indicate that while the systemic inhibition of NF-kB protects from silica-
induced lung injury, epithelial cell specific NF-kB inhibition appears to aggravate the outcome of experimental silicosis.
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Introduction
Chronic occupational or environmental exposure to silica is
associated with the development of silicosis, a lung disease
characterized by granulomatous inflammation and pulmonary
fibrosis [1]. In spite of significant progress in its prevention, silicosis
remains a major global health problem associated with a high
morbidity and mortality for which no specific therapy is available
[1]. Silica-induced inflammation is a complex process in which the
interaction of silica particles with lung cells is followed by the
release of inflammatory mediators [2]. Among these mediators,
tumor necrosis factor alpha (TNFa) plays a fundamental role in
the pathogenesis of silica-induced lung injury. Mice exposed to
silica demonstrate enhanced TNFa production in their lungs in a
manner that precedes the inflammatory response and the
accumulation of lung collagen [3].
NF-kB is a transcription factor that plays a fundamental role in
inflammation [4–6]. NF-kB is a protein complex formed from the
homo or heterodimers of any of the five members of the rel
transcription factor family [REL (c-Rel), RELA (p65), RELB (Rel
B), NFKB1 (p50/p105), and NFKB2 (p52/p100)] [4–6]. Under
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group [NFKBIA (IkBa), NFKBIB (IkBb), and NFKBIE (IkBe) are
the key members) of NF-kB sensitive proteins that limits NF-kB
nuclear translocation and inhibits its ability to bind the promoter
region of sensitive genes [6]. NF-kB activation can occur in several
pathways: most commonly, it is triggered in a canonical manner in
response to inflammatory cytokines (such as TNFa), engagement
of T cell receptor, or lypopolysaccharide (LPS) that induces rapid
phosphorylation, at Ser32 and Ser36 residues, of IkB by the IkB
kinase complex [consisting of the catalytic subunits CHUK
(IKKa) and IKBKB (IKKb)] and several copies of the regulatory
subunit called NF-kB essential modifier. Phosphorylated IkBa
undergoes ubiquitin-induced degradation by the 26S proteosome
and allows the nuclear translocation of the NF-kB, NFKB1-RELA
dimers [4–6]. A subset of NF-kB activating stimuli such as
stimulation of CD40 activate the non-canonical, or alternative,
pathway in which activation of catalytic subunits CHUK results in
the formation of NFKB2 (p52) from p100 and the generation of
NFKB2-RELB heterodimers that target distinct kB elements [4–
6]. Activation of this alternative pathway of NF-kB is not
associated with formation of NFKB1 (p50) dimers [6].
Following inhalation into the lower respiratory tract silica
particles interact with epithelial cells and macrophages inducing
NF-kB activation [7–9]. Binding of NF-kB to DNA promotes the
transcription of genes involved in mediating the inflammatory
(TNFa) and fibrotic (collagens) responses to silica in mice [10–12].
Because of the potential importance of NF-kB in the pathogenesis
of silicosis, this transcription factor has been considered a primary
target to antagonize silica-induced inflammation in the lung
[10,11,13]. However, the long-term biologic effects of inhibiting
NF-kB in vivo in response to silica are unknown.
Due to the lack of treatment for silicosis, lung transplantation is
considered the only a therapeutic alternative. In the present work
we characterized the outcome of patients that received lung
transplantation for the treatment of their silica-induced respiratory
failure. We also treated silica exposed C57BL/6 mice with a
pharmacologic inhibitor (BAY 11-7085) of NFKBIA (IkBa)
phosphorylation [14] or exposed transgenic mice expressing a
dominant negative NFKBIA (IkBa) mutant protein [15,16] under
the control of epithelial specific promoters mice to silica to
determine whether the systemic or epithelial inhibition of NF-kB
activation is a valid therapeutic approach in silicosis.
Methods
Study population
The University of Pittsburgh Institutional Review Board
approved the procedures used in this study and information was
minimized to comply with HIPPA regulations. We identified 990
patients that received lung transplantation at the University of
Pittsburgh during the period of May 1986 to July 2007. From this
database we selected patients that received lung transplantation for
the diagnosis of silicosis (n=13) and assessed the overall survival
and rate of graft rejection, by measuring the development of
bronchiolitis obliterans (BO). We compared the rate of rejection to
that of patients with idiopathic pulmonary fibrosis (IPF) that was
selected as a control group because survival benefit of lung
transplantation has been identified for these patients [17].
Inclusion criteria for IPF included histological evidence of usual
interstitial pneumonia (UIP) in the explanted lungs and fulfilled the
criteria established by the American Thoracic Society and
European Respiratory Society [18,19]. Diagnosis of silicosis or
UIP was unequivocally established by blind re-evaluation
(S.Yousem). Upon further evaluation of explanted lungs, two of
the twelve patients with diagnosis of silicosis demonstrated
evidence of coexistent pneumoconiosis or Kaplan syndrome and
were withdrawn for further analysis. Characterization of the
TNFa expression and the NF-kB activation was conducted by
immunohistochemistry in paraffin-embedded lung tissues (4 mm)
isolated from silicosis patients at time of lung transplantation.
Silica and BAY 11-7085 Treatment
All procedures were approval by the Institutional Animal Care
and Use Committee of the University of Pittsburgh. Specific
pathogen-free female C57BL/6 (Charles River laboratories,
Kingston, NY), and mice genetically deficient in both
(p55p752/2) TNF receptors (The Jackson Laboratory, Bar
Harbor, ME) weighing 20 to 25 grams were housed in
pathogen-free cabinets as previously described [12,20]. Animals
were exposed to silica (0.2 g/kg) or saline (control) as previously
described [12,20] and killed at selected times (3, 7, 14, and 28 d)
after silica exposure. Prior to exposure, crystalline silica (a-quartz,
average diameter: 1.7 mm, U.S. Silica Co., Berkeley Springs, WV)
was sterilized (200uC, 16 h) to inactivate endotoxin contamination.
Silica suspension in sterile 0.9% NaCl (Baxter Healthcare Corp.,
Deerfield, IL) was prepared by sonicating immediately prior to
intratracheal instillation [12,20]. Groups of mice received 10 mg
of BAY 11-7085 (BIOMOL International L.P. Plymouth Meeting,
PA)/Kg body weight/day/28 d by i.p. injection in 180 mlo f
vehicle (0.5% (w/v) methylcellulose in water) or vehicle alone
(control). Mice were anesthetized with sodium pentobarbital
(200 mg/kg i.p., Henry Schein, Indianapolis, IN) followed by
exsanguination via severing of the posterior abdominal aorta. All
the lung samples were harvested at a terminal anesthesia point,
snap frozen in liquid nitrogen, and stored at 280uC for RNA or
hydroxyproline content analysis. Lung hydroxyproline was
determined according to the method of Kivirikko et al. as
previously described [12,20].
Generation of CCSP and SPC-dnIkBa transgenic mice
To inhibit NFKBIA (IkBa) in the airway epithelium, a CCSP-
dnIkBa construct was generated by cloning a dominant-negative
(dn) IkB mutant [15] under the regulation of rat Clara cell
secretory protein (CCSP) promoter [21]. Details of the generation
of the CCSP-dnIkBa mice are included in the supplemental
information (Method S1). In addition, transgenic SPC-dnIkBa
mice (kind gift of Christopher Wilson) were generated at the
University of Washington and have dnIkBa under the regulation
of the human SPC (SFTPC) promoter as previously described
[16]. CCSP- and SPC-dnIkBa mice were crossed with C57BL/6
strain mice for a minimum of 7 generations before used in
experiments. Transgene negative littermates were used as controls.
Mice were housed under specific-pathogen free conditions in
filtered-air cages, and permitted unlimited access to sterile food
and water.
Morphology and Morphometry
Inflammatory cell infiltration was determined by morphometric
assessment (conducted blindly by G. Lungarella) and expressed as
percentage volume-densities of fibrosis [Vv(f)] was measured
according to the stereological principle of Glagoleff and Weibel
as previously described [22,23]. Point counting was performed at a
magnification of 6100, by determining 20 random fields per slide
and using a multipurpose grid to count 45 points/field to a total of
900 points/specimen. This method measures inflammatory cell
infiltration within alveolar septae and alveolar spaces with
deposition of extracellular matrix.
NF-kB in Silicosis
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PCR) assay
To adequately cover the TNFa and NF-kB pathway and
targeted cytokines, 40 transcripts selected were analyzed by qRT-
PCR. Total RNA was isolated with TRIzol reagent (Invitrogen,
Carlsbad, CA) and quantity was assessed by absorbance
(NanoDrop, Thermo Scientific, Pittsburgh, PA). RNA (100 ng)
was reverse transcribed (High Capacity cDNA Archive Kit,
Applied Biosystems Inc., Foster City, CA) and cDNA was PCR
amplified with primers and TaqMan Universal PCR Master Mix
(Applied Biosystems). Arranged into functional groups, primers
(SABiosciences, Frederick, MD) included: A. TNF pathway group (19
transcripts): TNF, TNFSF10, TNFSF14, TNFRSF1A,
TNFRSF1B, TNFRSF10B, CD27, CD40, LTBR, TNFAIP3,
TRAF2, TRAF3, TRADD, TBK1, FADD, CFLAR, RIPK1,
RIPK2, and MAP3K1, B. NFKB pathway group (9 transcripts):
NFKB1, NFKB2. IKBKB, IKBKE, IKBKG, REL, RELA,
RELB, and CHUK, and C. Cytokine group (12 transcripts mRNAs):
CCL2, IL1B, IL6, CSF2, CSF3, IFNG, IRAK1, IRAK2, NLRP2,
KAT2B, STAT1, and EGR1 (All abbreviations are current Entrez
Gene official symbols and official full names are presented in
Table S1). Analysis was performed with an Applied Biosystems
7900HT System (95uC 10 min; 40 cycles 95uC, 15 s; 60uC,
1 min). The expression of each transcript relative to Heat shock
protein 90 kDa alpha (cytosolic), class B member 1 (HSP90AB1)
transcript level was determined using the 2
2DDCT method [18]
and normalized to strain-matched mice exposed to saline.
Northern Analysis and Ribonuclease Protected Assays
Analysis of the expression of collagen, type I, alpha 1 (COL1a1),
TNFa, and RPS18 (18S) mRNA was conducted as previously
described [12,20,23]. Metalloproteinase 2 (MMP2), and tissue
inhibitor of metalloproteinase 1 (TIMP1) transcript levels were
determined by a ribonuclease protection assay (RiboQuant
TM,
Becton, Dickinson and Company, Franklin Lakes, NJ).
Isolation of Clara and Alveolar Epithelial type II (AEII) cells,
and electrophoretic mobility Shift Assay (EMSA), and
Western Blot assays
Clara and AEII cells were isolated from the lung of transgenic
and wild-type mice as previously described [24,25]. Complete
description of the isolation protocol is included in supplemental
data (Methods S1). Nuclear extracts from Clara cells, AEII cells, or
the lungs of silica-treated mice were prepared as previously
described [23,26]. Complete description of the EMSA protocol is
included in supplemental data. IkB expression was studied by
proving proteins with an affinity purified rabbit polyclonal
antibodies specific to total or phospho-IkB [PhosphoPlus IkB-
alpha (Ser
32) antibody kit, New England Biolabs, Ipswich, MA].
Quantification of apoptosis in lung tissues by Terminal
deoxynucleotidyl transferase-mediated dUTP nick end
labeling (TUNEL)
Apoptotic cells in lung tissues from mice treated with silica or
silica plus Bay 11-7085 (n=5 mice/group) was performed using a
TUNEL assay (Travigen Laboratories, Gaithersburg, MD). The
mean of the numbers of TUNEL-positive cells was determined
using 3 sections/mouse (6400 light microscopy) as previously
described [27].
Statistics
We analyzed both overall survival and rejection-free survival,
using the date of transplant as the start date of follow-up. Survival
curves were computed using the Kaplan-Meier method. Differ-
ences in survival according to primary diagnosis were assessed
using the logrank test and the Cox proportional hazards model.
Differences between murine strains were analyzed using ANOVA
with Fisher’s PLSD test for pair-wise comparison (statview 4;
Abacus Concept, INC., Berkeley, CA). The differences in
transcript levels are expressed as fold change of silica-treated mice
compared to saline exposed mice and significant differences were
determined by One-way Analysis of Variance with Holm-Sidak all
pairwise multiple comparison procedure. Values are expressed as
mean6SEM, and p value,0.05 was considered significant.
Results
Patients with silicosis have poor prognosis following lung
transplantation
Characteristics of the patients with silicosis and IPF are
described in Table 1. We analyzed both overall and rejection-
free survival of patients with silicosis or IPF, using the transplant
date as the start of follow-up. Ten of the 11 patients with silicosis
(average age 52.468.6 yr) received single lung transplantation
(SLT) and 1 received a double lung transplant (DLT). Of the 79
patients with IPF (average age 54.069.9 yr), 71 patients received
SLT and 8 patients received DLT. Survival at 30-, 60-, or 90-d did
not differ between the two groups as assessed by the Kaplan-Meier
method. Differences in survival according to primary diagnosis
also were assessed using the log-rank test and the Cox proportional
hazards model. Median survival of silicosis patients (2.4 yr,
Figure 1A) was somewhat less than that of IPF patients (5.3 yr;
lower confidence bounds 0.2: 2.8 yr; p=0.07 by the logrank test;
Figure 1A). This analysis is confounded by gender (i.e., no female
silicosis patients) as survival differed between sexes for IPF
patients. Thus, female IPF patients were transplanted at a
significantly younger age (51.569 years) than their male
counterpart (55.9610.2 yr) and demonstrated a significant
(p,0.005) survival difference (11.6 yr) when compared to male
patients with IPF (3.5 yr). All 11 patients who received lung
transplantation for silicosis died during the follow up, while only
37 deaths occurred among the 79 patients with IPF during follow-
up. Transplantation type, SLT versus DLT, did not affect survival
outcome.
Rejection of the transplanted lung was defined as the
development of bronchiolitis obliterans syndrome (BOS). BOS
was defined by an irreversible ($20%) decrease in forced
expiratory volume in one second (FEV1) using each patients’ best
post transplant FEV1 after lung transplant as baseline, and the
development of obliterative bronchiolitis (OB) in lung biopsy of the
transplanted lung [28]. The rate of graft rejection increased in
silicosis patients (Figure 1B) as compared to IPF patients (p,0.05,
by the logrank test). Median graft survival was 0.9 and 2.4 yr,
respectively, for the silicosis and IPF groups. A lower confidence
bound for the silicosis group was 0.22 yr; a 95% confidence
interval for the IPF group was 1.5: 3.6 yr.
Enhanced macrophage TNFa expression and epithelial
NF-kB activation in silicosis
TNFa expression and NF-kB activation was determined by
performing immune staining in paraffin embedded sections of lung
tissues isolated from the lungs of subjects afflicted with silicosis at
the time of lung transplantation. In all 11 silicosis patients, large
areas of the lung parenchyma were replaced by coalescence of
silicotic nodules (Figure 2A). These nodules contain fibrinous
material, had few cells, and did not demonstrate TNFa
immunostaining (Figure 2A). In contrast, TNFa immunostaining
NF-kB in Silicosis
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to the silicotic nodules, which was confined to primarily to
macrophages (Figure 2B), and was particularly strong in
macrophages that exhibit excessive silica particles in phagosomes
(Figure S1). Immunostaining for NF-kB activation was predom-
inantly detected in the nuclei of epithelial cells adjacent to TNFa
immunostaining macrophages (Figure S2).
Lung Transcripts for TNFa, NF-kB, and cytokines
increased in silica-treated mice
To ascertain whether TNFa or NF-kB signaling pathways and
targeted cytokines were altered in silica treated mice, 40 lung
transcripts were assessed in the lung of C57BL/6 mice at 3, 7, 14
and 28 d after silica exposure. Overall, 26 transcripts increased
(p,0.05) within 3 d and were slightly higher than the mean level
Figure 1. Patients with silicosis have poor outcome following lung transplantation. Figure 1 illustrates the survival rates (1A) and the
rejection free time (1B) for patients with idiopathic pulmonary fibrosis (IPF; n=79) or silicosis (n=11) following lung transplantation. Survival curves
were computed using the Kaplan-Meier method. Differences in survival according to primary diagnosis were assessed using the logrank test and the
Cox proportional hazards model as described in the text.
doi:10.1371/journal.pone.0005689.g001
Table 1. Patient Characteristics.
IPF (n=79) Silicosis (n=11) (p-value)
No. of Patients % No. of Patients %
Sex
Male 53 67.1 11 100.0
Female 26 32.9 0 0.0 (p=0.03)
Race
Caucasian 73 92.4 11 100.0
African-American 5 6.3 0 0.0
Hispanic 1 1.3 0 0.0 (p=1.0)
Age at Transplant (years)
Mean 54.5 52.4
SD 10.3 8.6
N 79 11 (p=0.31)
Pre-transplant FVC (L)
Mean 1.9 1.9
SD 0.69 0.77
N 74 10 (p=0.76)
Pre-transplant 6MWD (m)
Mean 1157.0 993.2
SD 293.6 300.3
N 63 10 (p=0.13)
P-value denotes the statistical difference between Patients with IPF and those with silicosis.
doi:10.1371/journal.pone.0005689.t001
NF-kB in Silicosis
PLoS ONE | www.plosone.org 4 May 2009 | Volume 4 | Issue 5 | e5689at 7 d (Figure 3A and Figure 3B). At 28 d, 38 of the 40 transcripts
were increased (only CHUK and EGR1 were not significantly
increased). Of the 40 transcripts measured, TNFa increased the
most (,90-fold). TNFa receptors, TNFRSF1B and TNFRSF1A,
increased, as did transcripts that are rapidly induced by TNFa,
TNFAIP3 and RIPK2 (Figure 3C). All 19 TNF signaling pathway
transcripts increased by 28 d (Figure 3A). Albeit somewhat less the
TNF signaling pathway, NF-kB signaling pathway transcripts also
increased in mouse lung following silica exposure. At 28 d,
NFKB1 (p50) increased ,5–10 fold and Rel/NFKB family
transcription factors (REL, RELA, RELB) increased ,5–15 fold
(Figure 3C). Only 1 (CHUK) of 9 transcripts in the NF-kB
signaling pathway was not significantly different from control by
28 d. In addition, 11 of 12 cytokine transcripts increased
significantly with the progression of treatment. Of these, cytokine
controlling the production, differentiation, and function of
Figure 2. TNFa expression in silicotic lung is predominantly identified in macrophages. Panel A show low photomicrograph (6200) of
lung tissue isolated from a silica exposed subject at the time of lung transplantation. Lung parenchyma is replaced by silicotic nodule characterized
by a dense palisade of fibroblast surrounding a central fibrinous core that is devoided of cells and abuts the distal airway. Alveolar macrophages
accumulate in relatively normal alveolar areas adjacent to the silicotic nodule (circle). Panel B show high (6400) magnification of the area identified in
panel A, illustrating immunochemistry signal with anti-TNFa antibody that is confined to cells with macrophage morphology.
doi:10.1371/journal.pone.0005689.g002
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GM-CSF), and of granulocytes (CSF2: a.k.a. G-CSF; CCL2) are
noteworthy (Figure 3C). In addition, transcripts encoding
interleukins (IL1B, IL6), IFNG, and the downstream transcription
activator, STAT1, increased markedly (,8–20 fold at 28 d).
TNFa receptors mediate NF-kB activation in experimental
silicosis
We have previously reported that TNFa receptors play a
fundamental role in experimental silicosis and TNFa receptor
deficient mice are protected from silica-induced lung fibrosis
[12,20,21]. Here we show that TNFa-receptor mediated signaling
is an important determinant of the NF-kB activation in the mouse
lung in response to silica. Instillation of silica particles increased
phophorylated IkB moiety (Figure 4). This increase was followed
by IkB rapid degradation and eventual disappearance of (total
IkB) in the lungs of silica-sensitive C57BL/6 mice. In contrast to
C57BL/6 mice, these changes in IkB did not take place in the
lungs of double (p55p75) TNFa receptor deficient mice developed
in the same silica-sensitive C57BL/6 genetic background. Silica-
induced degradation of phospho IkB is associated with NF-kB
activation in the lungs of C57BL/6 (Figure 4). Analysis of NF-kB
gel shift in lung nuclear extracts show that silica induces two
bands: a lower band representing the p50-p50 (NFKB1-NFKB1)
homodimer, present in both the C57BL/6 and the double
(p55p752/2) TNFa receptor deficient mice, and an upper band,
only observed in the lungs of C57BL/6 mice, representing the
p50-p65 (NFKB1:RELA) heterodimer (Figure 4). Supershift assays
confirmed that the lower band could be competed by excess cold,
but not by mutant, probe while the upper band could be displaced
by incubation of the nuclear extract with an antibody against the
p50 or the p65 complex (Figure 4). These data indicate that silica
induces a canonical, TNFa receptor-mediated, activation of NF-
kB in the mouse lung.
Following the early activation of NF-kB, lung IkB mRNA
increased in silica-exposed C57BL/6 mice (not shown) and IkB
protein returned to baseline (Figure 4). Enhanced NF-kB
activation was appreciated in the lungs of silica-exposed C57BL/
6 mice for the entire duration of the experiments, and it was
readily demonstrated 14 and 28 d after silica exposure (Figure 5).
Therefore, it is conceivable that inhibition of NF-kB activity could
in turn modulate expression of NF-kB sensitive genes and alters
the development of silica-induced lung injury in these mice.
Systemic inhibition of NF-kB activity ameliorates silica-
induced lung injury in mice
To investigate whether inhibiting systemic or lung epithelial
cell-specific NF-kB activation is protective in the development of
Figure 3. Tumor necrosis factor alpha (TNFa), nuclear factor kappa B (NFKB) and associated cytokines increased in mouse lung
following silica treatment. Mice (n=5 C57BL/6J mice/group) were treated with silica, lung mRNA was obtained at 3, 7, 14, and 28 days, and 40
transcript levels were assessed by qRT-PCR. (A) Self-organizing map visualization of transcripts in Tree View. The order of the transcripts is greatest
(top) to lowest (bottom) as measured on day 28. (B) Visualization of Mean Tendency of the 40 transcripts measured. Values are mean6standard error
and *p,0.05 as determined by One way analysis of variance with all pairwise multiple comparison procedures (Holm-Sidak method). (C) Transcript
levels of selected members of TNFa signaling, NFKB signaling, and downstream cytokine families. All abbreviations are current Entrez Gene official
symbols and official full names are presented in Table S1.
doi:10.1371/journal.pone.0005689.g003
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Systemic inhibition of NF-kB activation was accomplished using a
novel pharmacologic agent, BAY-117821, which irreversibly
inhibits TNFa-induced phosphorylation of IkB in human
endothelial cells, and NF-kB activation in silica stimulated
macrophages [14,23]. In preliminary studies, dose responses
(2.5–50 mg/kg) were tested and 10 mg/kg bwt/d (180 ml 0.5%
(w/v) methylcellulose i.p.) was capable of consistently inhibiting
the silica-induced activation of NF-kB in multiple organs including
the lungs of C57BL/6 mice without apparent toxicity to the mice
(Figure 5).
Silica treatment induced NF-kB activation, 14 and 28 d, in the
lungs of C57BL/6 mice (Figure 5A). Activation of NF-kB was
associated with increased inflammatory (TNFa), fibrotic (CO-
L1A1), and metalloproteinases (MMPs) transcripts in the lungs of
silica-exposed C57BL/6 mice (Table 2, Figure 3C, Figure 5B&C,
and Figure S3). Compared to control-treated mice, silica-exposed
C57BL/6 mice developed fibrosis with increased percentage of
fibrosis [(Vv(f)] (Table 2, Figure 5D), lung hydroxyproline
(Table 2), and apoptotic cells, identified as TUNEL positive cells
(Figure S4, and Table 3). Treatment of silica-exposed C57BL/6
mice with BAY 11-7085 compound inhibited the lung NF-kB
activation (Figure 5A), inflammatory and fibrotic transcripts
(Table 2, Figure 5B&C, and Figures S3), and histological evidence
of inflammatory infiltrates, fibrotic lesions (Figure 5D, Table 2),
and TUNEL positive cells (Table 3).
To achieve lung epithelial cell-specific inhibition of NF-kB
activation, we used mice in which dominant-negative IkBa
(dnIkBa:NFKBIA) mutant protein [15] is targeted to epithelial
cells under the control of the rat Clara cell secretory protein
(CCSP: Scgb1a1) or the human surfactant protein C
(SPC:SFTPC) promoter respectively. These dnIkBa mutant mice,
the mutant protein is resistant to phosphorylation and proteosomal
degradation [15,16] and inhibit NF-kB activation in those cells in
which the transgene is expressed (Figure 6). To confirm that that
NF-kB activation was impaired in the epithelium of these mice we
isolated Clara or alveolar epithelial type II cells from these
transgenic mice and non-transgenic littermate controls following
Figure 4. TNFa receptors mediate NF-kB activation in experimental silicosis. Western blot (upper panel) representing expression of total
and phosphorylated IkB (phospho IkB) in the lungs of silica-sensitive C57BL/6, or double (p55/p752/2) TNFa receptor deficient mice following the
intratracheal instillation of silica particles as described in the text. Lower panel illustrates the DNA binding activity of NF-kB in crude nuclear extracts
from whole lung isolated from C57BL/6, and double (p55/p752/2) TNFa receptor deficient mice after silica exposure. Silica induces two bands: a
lower band representing the p50-p50 homo-dimer, present in both the C57BL/6 and the double (p55p752/2) TNFa receptor deficient mice, and an
upper band, only observed in the lungs of C57BL/6 mice, representing the p50-p60 heterodimer. Excess probe represents NF-kB binding in lung
nuclear extract of a silica-treated mouse, assayed in the presence of excess unlabelled oligonucleotide as a competitor. Competition assays were
performed using 400 times excess of unlabeled probe or NF-kB mutant oligonucleotide (Santa Cruz). Supershifts were performed by adding to the
binding mixture antibodies to p50 (sc1190X) or to p65 (sc372X) or against C-Jun/AP-1 (sc44X) (Santa Cruz) before adding the labeled probe to the
mixture.
doi:10.1371/journal.pone.0005689.g004
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PLoS ONE | www.plosone.org 7 May 2009 | Volume 4 | Issue 5 | e5689Figure 5. Systemic inhibition of NF-kB activity ameliorates silica-induced lung injury in mice. A) DNA binding activity of NF-kB in crude
nuclear extracts from whole lung isolated from C57BL/6 mice 14 and 28 days after silica, or silica+BAY exposure. Excess probe represents NF-kB
binding in lung nuclear extract of a silica-treated mouse, assayed in the presence of excess unlabelled oligonucleotide as a competitor. Antibody
supershifts were performed using the nuclear extract of a C57BL/6 silica-treated mouse as described in Methods section. B) Northern blot analysis of
TNFa, a1(I) collagen, and 18S (loading control) mRNA expression in mouse lung 14 days following the intratracheal injection of saline as control, silica
alone, or silica+BAY as described in Methods section. C) The effect of BAY on metalloproteinase (MMPs) RNA expression in mouse lung following
silica exposure. Total lung RNA was isolated from the lungs of C57BL/6 mice 14 days after control, silica, or silica+BAY and subjected to RPA as
described in Methods section. D) The panels show low (6100) power magnification photomicrographs of the lung obtained from lung tissues of
C57BL/6 mice exposed to saline as control (A), silica (B), or silica+BAY (C) as described in the Methods section. TB=terminal bronchiole. Bar=20 mm.
Gel illustrations are representative of 4 different experiments.
doi:10.1371/journal.pone.0005689.g005
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PLoS ONE | www.plosone.org 8 May 2009 | Volume 4 | Issue 5 | e5689exposure to silica. In vivo exposure (28 d) to silica readily induced
NF-kB activation in Clara (Figure 6) or alveolar epithelial type II
cells isolated from the littermate wild-type mice (not shown). In
contrast, this NF-kB activation is greatly reduced in Clara or
alveolar epithelial type II cells isolated from CCSP- or SPC-
dnIkBa mice (Figure 6).
CCSP-dnIkBa mice reacted to silica exposure with decreased
lung inflammation as compared to littermate controls (Table 4).
This attenuated inflammatory response was associated decreased
TNFa transcripts and inflammatory cell infiltration [(Vv(f)] at 28 d
after silica exposure (Table 4). In contrast to these effects on
inflammation, lung hydroxyproline deposition increased in CCSP-
dnIkBa mice than in littermate controls (Table 4). Similarly,
CCSP-dnIkBa mice and wild-type littermate mice had nearly
equivalent increases in collagen and TIMP1 transcripts. However,
silica-induced lung MMP2 transcripts were less in CCSP-dnIkBa
mice as compared to C57BL/6 mice (Figure 7). Because NF-kB
can function as an anti-apoptotic factor, we evaluated the effect of
expressing the dnIkBa mutant in the lung epithelium of these
transgenic mice. CCSP-dnIkBa mice had increased apoptosis
(TUNEL positive cells) in their lungs when compared to their non-
transgenic littermate controls (Table 4). SPC-dnIkBa mice reacted
to silica exposure similar to that of CCSP-dnIkBa mice. SPC-
dnIkBa mice had decreased infiltrating cells, but accumulated
increased hydroxyproline and TUNEL positive cells in their lungs
when compared to littermate controls (Table 5).
Discussion
Silicosis remains a severe lung disease for which no successful
treatment is available. Here, we report that silica exposure leads to
large portion of the lung replaced by coalescing nodules with
proximal TNFa expressing macrophage and NF-kB activation in
epithelial cells. We also found that patients with silicosis had poor
survival and experienced early rejection of their lung grafts
following lung transplantation. Using a mouse experimental model
of silicosis in which the endotracheal instillation of silica
reproduces the silica-induced inflammation observed in humans
we show that systemic inhibition of NF-kB activation with a
pharmacologic inhibitor (BAY 11-7085) of IkBa (NFKBIA)
phosphorylation significantly decreases silica induced inflamma-
tion and fibrosis, with reduced collagen deposition and apoptosis.
In contrast, transgenic mice expressing a dominant negative IkBa
mutant protein under the control of epithelial specific promoters
demonstrate enhanced collagen deposition and apoptosis in their
lungs in response to silica.
The worldwide incidence and prevalence of silicosis is
uncertain, but is increasing in developing countries [29]. In the
United States the incidence and prevalence of silicosis is under-
estimated as silicosis is not a reportable disease and under
recognized [30]. Approximately 1.7 million people in the US are
occupationally exposed to silica [31–34] and as many as 119,000
are exposed above permissible levels [31–34] with the majority of
these individuals employed in mining, construction or maritime
activities. Consequently, an estimated 3,600–7,300 newly recog-
nized silicosis cases in the US from 1987 to 1996 [31,33,34].
Although preventive measures have significantly decreased the
mortality attributable to silica the reality is that that a large
number of silica-exposed patients are still dying as a result of this
disease [34]. While mortality is widely spread across the country,
nine states reported high rates of mortality, more than 2–3 deaths/
million people/year, with clusters of counties where mining is an
important activity contributing disproportionably (.14.8 deaths/
million/year) to this mortality [34]. A global health issue, silicosis
levels are rising in developing countries. For example, the silicosis
burden in China is growing (with ,7–10,000 new cases/yr) and is
extensive (.500,000 cases resulting in ,24,000 deaths/yr) [29].
Once established, silica-induced inflammation progresses even
after occupational exposure has ended, a phenomenon clearly
reproduced in experimental animals [35]. Using conventional
anti-inflammatory agents does not control silica-induced inflam-
mation and therefore, because of this lack of successful treatment,
lung transplantation has been proposed as an effective therapeutic
alternative [1]. However, very little published data is available to
support this postulate. A SLT was reported in a 23-yr male in 1972
with the patient surviving 10 months [36]. More recently, the
Table 2. The effect of BAY Treatment on Silica Induced Gene Expression.
Treatment Condition TNFaa 1(I) Collagen TIMP-1 MMP1
C57BL/6 Control 0.16460.004 0.31060.014 0.07960.06 0.01460.004
C57BL/6 silica 0.21560.006* 0.44060.019* 0.1060.010 * 0.02060.007*
C57BL/6 Silica+BAY 0.17260.005{ 0.34060.007{ 0.08860.013{ 0.01460.002{
*Statistically significant different when compared to control-treated mice.
{Statistically significant different when compared to silica exposed mice.
doi:10.1371/journal.pone.0005689.t002
Table 3. The effect of BAY Treatment on Silica Induced Lung Injury.
Treatment Condition n=6 mice/group
Hydroxyproline
(mg/Left Lung)
Volume-Density Fibrosis
Vv (%f)
TUNEL-Positive cells
(per mm
2)
C57BL/6 Control 46651 60.1 160.6
C57BL/6 Silica 87618* 1766.4* 64635*
C57BL/6 Silica+BAY 60612*{ 860.1*{ 25611*{
*Statistically significant different when compared to control-treated mice.
{Statistically significant different when compared to silica exposed mice.
doi:10.1371/journal.pone.0005689.t003
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translation cases, but no discussion of their outcome was available
[37].
In this report, we describe our experience at the University of
Pittsburgh (a post industrial city located in the heart of the mining
industry in Western Pennsylvania) with 11 silicosis patients that
received lung transplantation for this disease from 1986–2007.
The outcome of these patients was contrasted with that of a group
of 79 patients that received lung transplantation for IPF, a diffuse
parenchymal lung disease for which lung transplantation confers a
survival benefit [17]. Our data indicate that patients with silicosis
appear to have poor survival and greater rate of graft rejection,
Figure 6. Expression of a dominant-negative (dn) IkBa protein inhibits epithelial activation of NF-kB in response to silica. Lung
sections from CCSP-dnIkBa transgenic mice were stained with antibodies against the modified (dnIkBa)I kBa peptide. Panel A shows strong staining
in Clara cells of a dnIkBa transgenic mouse. Staining with the same antibody is absent in the non-transgenic littermate mouse in panel B. DNA
binding activity of NF-kB in crude nuclear extracts from Clara (C) cells isolated from the lungs of CCSP-dnIkBa transgenic mice, or their littermate
(wild-type) 28 days after exposure to silica or saline as controls as described in Methods section. Excess probe represents NF-kB binding in nuclear
extract from Clara isolated from silica-exposed littermate wild type mice, assayed in the presence of excess unlabelled oligonucleotide as a
competitor. Antibody supershifts were performed using the nuclear extract from Clara cells isolated form silica-exposed littermate wild type mousea s
described in Methods section.
doi:10.1371/journal.pone.0005689.g006
Table 4. Silica Induced Lung Injury in CCSP-dnIKBa mice.
Treatment Condition n=5 mice/group
Hydroxyproline (mg/Left
Lung)
Volume-Density Fibrosis
Vv (%f)
TUNEL-Positive cells
(per mm
2)
NT Littermate Control 39.764.0 460.7 0.5
CCSP-dnIkB Control 60622 60.5 4
NT Littermate Silica 7663* 1263* 2668*
CCSP-dnIkB Silica 8565* 760.5*{ 4661*{
*Statistically significant different when compared to control-treated mice.
{Statistically significant different when compared to silica exposed NT littermate mice.
doi:10.1371/journal.pone.0005689.t004
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with IPF following lung transplantation. Our analysis is limited by
the small size and more importantly by gender differences in lung
transplant survival among patients with IPF. Female IPF patients
were transplanted at a younger age and had better survival
outcome and lower rejection rates when compared to their male
counterparts. The reasons for the gender difference in survival
following lung transplantation are unknown and are worthy of
additional study.
To further our understanding of the pathogenesis of silicosis
we used well-characterized mouse model in which silica
exposure produces lung inflammation and parenchymal nodules
comparable to those observed in humans exposed to silica.
Using this experimental model, silica induced rapid (with in
minutes) and persistent (identified 14 and 28 d after a single
intratracheal instillation) activation of NF-kB in the lung and
that TNFa receptors greatly contribute to this activation.
Previously, TNFa has been implicated as a central mediator
in the pathogenesis of silicosis. Piguet et al. reported that the
exposure of mice to silica increased lung TNFa mRNA levels
[3], which preceded the development of lung inflammation and
collagen deposition [11,12]. Furthermore, these investigators
were able to abrogate silica-induced inflammation and lung
fibrosis with the administration of anti TNFa antibodies or
TNFa receptors that antagonized the bioactive TNFa [3,38].
Similarly, we have previously reported that animals deficient in
TNFa receptors are protected from silica-induced inflammation
and fibrosis [12,20]. In humans, compelling evidence indicates
that polymorphism of the TNFa gene promoter (TNF-308:
denominated TNF-A allele 2) is associated with silicosis disease
Figure 7. Clara cell expression of a dominant-negative (dn) IkBa protein alters TNFa, and MMP2, but not a1(I) collagen and TIMP-1,
mRNA expression in response to silica. Densitometry analysis of Northern blots of TNF, a1(I) collagen, MMP2, TIMP-1, and 18S (loading control)
mRNA expression in CCSP-dnIkB mouse lung 28 days following the intratracheal injection of saline as control, or silica as described in the Methods
section. Compared to their wild type littermates, CCSP-dnIkB transgenic mice significantly inhibited (P,0.05) the enhanced expression of TNFa and
MMP2 mRNA induced by silica in the mouse lung. Figure illustrate results obtained from five set of mice exposed to silica or saline as control. *
Indicates statistically significant difference compared to saline treated mice. { Indicates statistically significant difference compared to wild-type non-
transgenic mice.
doi:10.1371/journal.pone.0005689.g007
Table 5. Silica Induced Lung Injury in SPC-dnIkBa mice.
Treatment Condition n=6 mice/group
Hydroxyproline (mg/Left
Lung)
Volume-Density Fibrosis Vv
(%f)
TUNEL-Positive cells
(per mm
2)
NT Littermate Control 47620 0
SPC-dnIkB Control 51692 60.5 4
NT Littermate Silica 97610* 25642 7 614
SPC-dnIkB Silica 11767*{ 1864*{ 48618*{
*Statistically significant different when compared to control-treated mice.
{Statistically significant different when compared to silica exposed NT littermate mice.
doi:10.1371/journal.pone.0005689.t005
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miners [39].
TNFa mediates its biologic action by binding to two receptors of
tumor necrosis factor receptor superfamily, member 1A
(TNFRSF1A: p55) and 1B (TNFRSF1B: p75) [40,41]. In this work
we find that TNFa receptors contribute to the canonical activation
of NF-kB in the mouse lung in response to silica. Previously, we
reported that doubleTNFa receptor deficientmicefailed to activate
NF-kB in their lungs in response to silica [12]. Centrally located in
the TNFa signal pathway, NF-kB activation mediates the
inflammatory and cell survival effects of TNFa and therefore
constitutes a logical target for antagonism in silicosis [7–13]. The
long-term effects of such inhibition are not well understood.
The present work underscores the importance of the specificity
of the NF-kB antagonism during lung inflammation. Thus, both
the inflammatory and fibrotic responses to silica was ameliorated
by systemic inhibition of NF-kB activation with BAY-117821, an
irreversibly inhibitor of TNFa-induced phosphorylation of IkBi n
human endothelial cells [14]. In contrast, although the lung
epithelial cell specific inhibition of NF-kB also reduced TNFa
expression and the infiltration of inflammatory cells in the lung, it
accentuated the apoptotic process and enhanced the fibrosis
response by promoting the deposition of collagen and decreasing
the matrix remodeling in the lung in response to silica.
These data stress two aspects of the pathophysiology of silicosis.
The first aspect is that although silica enters the body via the
respiratory system it triggers a systemic response characterized by
stimulation of bone marrow and the migration of bone marrow-
derived cells into the lung [42–45]. Published data in experimental
models of lung fibrosis indicate that although this response is
dominated by migration of neutrophils and lymphocytes [42–45] it
also includes the homing of profibrotic fibrocytes [46,47].
Characterized by their expression of hematopoietic markers (such
as CD45) fibrocytes also express collagen and contribute actively
to the deposition of this protein in the lung [47]. Mobilization and
homing of fibrocytes into the lung is facilitated by their expression
of chemokine receptors, such as CXCR4, and the enhanced
expression in the injured lung of the cognate ligands for these
receptors (i.e., stromal cell derived factor1 alpha and CXCL12).
Because expression of these ligands is sensitive to NF-kB
regulation [48], early inhibition of the NF-kB activation could
reduce the migration of these cells and protect the lung from
further injury.
The second aspect is that epithelial cells responses contribute to
inflammation in silicosis. Consistent with this statement, CCSP-
dnIkB as well as SPC-dnIkB transgenic mice exhibit reduced
TNFa mRNA expression and are less inflamed than their wild-
type littermates. However, these mice exhibit more robust
accumulation of collagen in response to silica. These data
underscore the importance of the epithelial specific inhibition of
NF-kB, which has previously been reported to increase MMPs in
the lungs of silica-exposed animals depleted of Clara cells [49]. In
contrast, we find that silica induced expression of the MMP
inhibitor, TIMP1, in the lung of mice, and this enhanced
expression was not altered in the lungs of the CCSP-dnIkB mice.
Therefore, these data suggest that the decrease MMPs expression
originated by the Clara cell specific inhibition of NF-kB would
create an imbalance of the ability of lung to remodel in favor of
matrix deposition. Our data are also consistent with the hypothesis
that lung epithelium harbors a small number of stem cells that are
resistant to toxins and are fundamental to the maintenance of
homeostasis of the lung [50]. Therefore, it is plausible that
expression of the IkB repressor under specific epithelial promoters,
such as CCSP or SPC, results in reduced activation of NF-kBo n
these cells rendering them more sensitive to apoptosis thus
compromising their ability to repair the injured epithelium.
In summary, the present work re-emphasizes that silicosis
remains a serous lung disease for which no specific treatment is
successful. Although limited by its size, our data support that
patients with silicosis appear to have poor outcome following lung
transplantation. Experimental data indicate that TNFa receptors
contribute to the silica-induced activation of NF-kB in the lung
and our data suggest that early and systemic antagonism of this
signal transduction ameliorates lung inflammation and benefits
outcome in experimental silicosis. Because systemic antagonism of
TNFa in humans is currently possible with a variety of strategies
such as use of antibodies or recombinant receptors that bind and
antagonize TNFa it would be appropriate to prospectively study
the potential therapeutic role of such antagonism in modulating
silica-induced lung injury and improving the outcome of lung
transplantation for silicosis.
Supporting Information
Figure S1 Silica exposed Macrophages express TNFa. High
(6400) magnification photomicrograph, using polarized light of
the same area illustrated in Figure 3B, to illustrate that TNFa
expression is predominantly located in macrophages laden with bi-
refringent silica particles.
Found at: doi:10.1371/journal.pone.0005689.s001 (7.06 MB
DOC)
Figure S2 TNFa and NF-kB expression in silicosis. Panel A
show photomicrograph (6100) illustrating hematoxyllin and eosin
staining of silicotic nodule involving a terminal airway in lung
tissue isolated from a silica exposed subject at the time of lung
transplantation. Insert (circle) represents an area adjacent to the
silicotic nodule to illustrate sequential HE (D 6200), and
immunohistochemistry staining against TNFa in interstitial
macrophages (arrows) loaded with dust (E 6200), or nuclear
localization on NF-kB in adjacent epithelial cells (E 6200).
Found at: doi:10.1371/journal.pone.0005689.s002 (5.84 MB TIF)
Figure S3 The Effect of BAY treatment on silica-induced gene
expression in the mouse lung. Northern blot analysis of TNF, a1(I)
collagen, TIMP-1, and 18S (loading control) mRNA expression in
mouse lung 28 days following the intratracheal injection of saline
as control, silica alone, or silica+BAY as described in Methods
section. Gel is representative of result obtained with three different
sets of animal exposures.
Found at: doi:10.1371/journal.pone.0005689.s003 (0.34 MB TIF)
Figure S4 The effect of systemic or lung epithelial specific NF-
kB inhibition on the induction of apoptosis (TUNEL staining) in
the lung of silica exposed mice. Apoptosis was characterized by
terminal deoxynucleotidyltransferase dUTP nick end-labeling
(TUNEL) as described in Methods section. The panels show low
(6100) power magnification photomicrographs of the lung
obtained from lung tissues of C57BL/6 mice exposed to saline
as control (A), silica (B), silica+BAY (D), or SPC-dnIkB transgenic
mouse (E) exposed to silica as described in the Method section.
Panel C show high (6400) magnification of TUNEL positive cells
identified in B. Panel F illustrates negative staining (by omission of
treatment with deoxynucleotidyltransferase enzyme) of a silica-
exposed tissue used as control to demonstrate stain specificity.
Found at: doi:10.1371/journal.pone.0005689.s004 (10.28 MB
TIF)
Table S1
Found at: doi:10.1371/journal.pone.0005689.s005 (0.07 MB
DOC)
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ods
Found at: doi:10.1371/journal.pone.0005689.s006 (0.05 MB
DOC)
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